SARS-CoV-2 IgG Levels Allow Predicting the Optimal Time Span of Convalescent Plasma Donor Suitability

SARS-CoV-2 IgG Levels Allow Predicting the Optimal Time Span of Convalescent Plasma Donor Suitability

Convalescent plasma (CP) has been in use for the treatment of numerous infectious diseases for more than a century, recently also for coronavirus disease 2019 (COVID-19). A major challenge for this treatment is identifying suitable donors with sufficient levels of functional antibodies and to determ...

Full description

Bibliographic Details
Main Authors: Sandra Laner-Plamberger, Nadja Lindlbauer, Lisa Weidner, Simon Gänsdorfer, Lukas Weseslindtner, Nina Held, Wanda Lauth, Georg Zimmermann, Jan Marco Kern, Fabian Föttinger, Laura Ombres, Christof Jungbauer, Eva Rohde, Christoph Grabmer
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Diagnostics
Subjects:
plasmapheresis
convalescent plasma
COVID-19
SARS-CoV-2 antibodies
Online Access:https://www.mdpi.com/2075-4418/12/11/2567

Similar Items

Similar Items